Comparative Complement Activation Study of Polypropylene Hollow Fibres of Two Different Makes in Static Condition

Abstract

The complement activation is one of the major problems encountered in the use of extracorporeal devices. The complement-activating potential of two polypropylene hollow fibres (used in membrane oxygenator) of different make and designated as F1 and F2 was tested with time (10, 30, and 180 minutes). The fibres were brought in contact with human blood under in vitro static condition for the comparison. A direct measurement of unadsorbed concentration of the complement protein, C3, present in the liquid phase of human blood before and after the contact with polymer was made using human C3 antisera. This gave a measure of C3 adsorption on the fibres with time and probably also gave an indirect measure of C3a in the blood. IgG was also estimated using antisera of human IgG. The total protein and albumin concentration were measured to obtain an overall adsorption profile of these protein on the fibre surfaces with respect to time. The results showed that C3 adsorption was taking place mainly through the alternative path-way over and above the classical one, being more in the case of F2 than Fl. SEM studies revealed poor adhesion of platelets on both fibres, though some activated platelets were also seen with slight deformation at 10 minutes and a few with prominent pseudopodia formations at a later time period on the surface of both fibres. The total protein adsorption was faster, and the surface pores of the F1 were found masked at 10 minutes observation. Later, desorption occurred making the pores visible at 180 minutes. The F2 surface examination showed a continuous deposition of protein layers with time, thereby masking the pores at 180 minutes. The present experimental finding and assessment favoured the F1 as a marginally better candidate to be considered for oxygenator development.

Keywords

complement activation platelet activation polypropylene hollow fibre

Get full access to this article

View all access options for this article.

References

1. Chenoweth D. E. (1988): Complement activation produced by biomaterials, Artificial Organs, 12(6): 502-504.

2. Nishida H. , Shibuya M. , Endo M. and Koyanagi H. (1996): Simple evaluation method of biocompatibility of artificial oxygenator hollow fibre, Artificial Organs, 20(12): 1292-1294.

3. Berger M. , Broxup B. and Sefton M. V (1994): Using Elisa to evaluate complement activation by reference biomaterials. Journal of Materials Science: Materials in Medicine, 5:622-627.

4. Tengvall P. , Lundstrom I. , Freij-Larsson C. , Kober M. and Wesslen B. (1993): Ellipsometric studies of antisera binding onto medical polyurethanes immersed in human plasma in vitro. Journal of Materials Science: Materials in Medicine, 4:305-310.

5. Ikeda Y. , Kohjiya S. , Yamashita S. and Fukumura H. (1991): Activation of complement in human serum by polyurethane having PEO-PTMO-PEO as soft segment. Journal of Materials Science: Materials in Medicine 2:110-117.

6. Lindhout T. , Blezer R. , Maassen C. , Heijnen V and Reutelingsperger C.P.M. (1995): Platelet procoagulant surface as an essential parameter for the in vitro evaluation of the blood compatibility of polymers. Journal of Materials Science: Materials in Medicine 6:367-372.

7. Tamiya T. , Yamasaki M. , Maeo Y. , Yamashiro T. , Ogoshi S. and Fujimoto S. , (1988): Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators. Ann thorac surg 46:47-57.

8. Oeveren W , Kazatchkine M.D. , Descamps-Latscha B. , Maillet F , Fischer E. , Carpentier A. and Wildevuur C.R.H. (1985): Deleterious effects of cardiopulmonary bypass: A prospective study of bubble versus membrane oxygenation. J. Thorac cardiovasc Surg 89:888-899.

9. Hugh T.E. (1984): Structure and function of the anaphylatoxins. Springer Semin Immunopathol 7:193-219.

10.

10. Liu L. and Elwing H. , (1994): Complement activation on solid surfaces as determined by C3 deposition and harmolytic consumption. J. Biomed. Mater. Res., 28:767-773.

11.

11. Mc Connell I. , Munro A. and Waldmann H. , (eds) in The immune System—A course on the molecular and cellular basis of immunity, Blackwell Scientific Publications, Boston, p40, 1981.

12.

12. Harris J. R. , (Ed) in Blood Cell Biochemistry, Vol. 1. Erythroid Cells, Plenum, New York, p92, 1990.

13.

13. Dvilansky A. , (1992) A novel agarose acrobeads protein A column for selective immunoadsorbance of whole blood, Performance, Specificity and Safety, Biomater. Artif Cells Immobilization Biotechnol., 20:23-30.

14.

14. Mollnes T. E. , Riesenfeld J. , Garred P , Nordstrom E. , Hogasen K. , Fosse E. , Gotze O. and Harboe M. , (1995) A new model for evaluation of biocompatibility: Combined determination of neoepitopes in blood and on artificial surfaces demonstrated reduced complement activation by immobilization of heparin, Artificial Organs 19:909-917.

15.

15. Cheung A.K. , (1990) Adsorption of unactivated complement proteins by hemodialysis membranes. Am J. Kidney Dis 14:472-477.

16.

16. Amadori A. , Candi P. , Sasdelli M. , et al. (1983) Hemodialysis leukopenia and complement function with different dialyzers. Kidney Int 24:775-781.

17.

17. Baier R.E. , Dutton R.C. , (1969). Initial events in interaction of blood with foreign surfaces, J. of Biomed Mater. Res. 3:191-206.

18.

18. Vroman L. , (1988) The life of an artificial device in contact with blood: initial effects and their effect on its final state. Bull NY Acad Med. 64:352-357.

19.

19. Brash J.L. , Scott C.F. , ten Hove P , Wojciechowski P , Colman R.W. , (1988) Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of contact and fibrinolytic systems. Blood 71:932-939.